Abcam 

$23.99
10
+$0.01+0.04% Tuesday 21:00

統計

當日最高
23.99
當日最低
23.99
52週最高
25.32
52週最低
12.48
成交量
7,430,229
平均成交量
5,734,542
市值
3.65B
市盈率
0
股息收益率
-
股息
-

股息

0%股息收益率
10年增長
N/A
5年增長率
N/A
3年增長率
N/A
1年增長率
N/A

收益

11Sep預期
Q1 2021
Q2 2021
Q4 2021
Q2 2022
Q3 2022
Q4 2022
Q2 2023
0
0.1
0.21
0.31
預期每股收益
0.1873
實際每股收益
0

人們還關注

此列表基於在 Stock Events 上關注 ABCM 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

關於

Health Technology
Biotechnology
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.
Show more...
首席執行官
Alan Hirzel
員工
1682
國家
US
ISIN
US0003802040
WKN
000A2QFYM

上市公司